TauroLock Hep100™

4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 100 units of heparin per ml (extra anticoagulant effect)

Specifications TauroLock Hep100™

TauroLock™ is a preventive lock solution suitable for central venous access within hemodialysis and oncology. In order to ensure a catheter with an optimum blood flow, it is important that the lock solution ensures both clotting and infection prevention. Taurolock’s double effectiveness prevents catheter infections and clot formation.

The double effectiveness of TauroLock Hep100* consists of the combination of:

  • Taurolidine, prevents bacterial growth and biofilm formation
  • 4% citrate, anti-clotting effect
  • Heparin 500 units per mL, extra anti-clotting effect

* Also available Taurolock Hep500 with 500 units of heparin per mL

Description: 4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 500 units of heparin per mL (extra anticoagulant effect)

Appearance: Glass ampoule, 3 mL

Package size: 10 items

Z-index number: 15942708

Item number: 1000473

Manufacturer: Tauropharm

Contact us

Kies een taal / Choose a language

Cablon Medical has developed a lead apron configurator that allows you to put together your own lead apron.